亚洲 · 股市与财经 · Vietnam Investment Review
China approves Jaypirca for chronic lymphocytic leukaemia treatment indications
Healthcare regulator National Medical Products Administration approved Innovent Biologics' drug Jaypirca for treating chronic lymphocytic leukaemia and small lymphocytic lymphoma…
在 Vietnam Investment Review 阅读全文 登录后可收藏MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (vir.com.vn)
